# Effect of Caloric Restriction on Fat Oxidation in Obese Men and Women (Magellan II)

> **NCT01616082** · NA · COMPLETED · sponsor: **AdventHealth Translational Research Institute** · enrollment: 39 (actual)

## Conditions studied

- Obesity
- Overweight
- Metabolic Diseases

## Interventions

- **BEHAVIORAL:** Low Calorie Diet (LCD)
- **DRUG:** Phentermine

## Key facts

- **NCT ID:** NCT01616082
- **Lead sponsor:** AdventHealth Translational Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2020-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01616082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01616082, "Effect of Caloric Restriction on Fat Oxidation in Obese Men and Women (Magellan II)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01616082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*